Immediate Postpartum Insertion of Copper Intrauterine Device in a Brazilian University Hospital: Expulsion and Continuation Rates

Abstract

Objective To evaluate the expulsion and continuation rates of the copper intrauterine device (IUD) inserted in the immediate postpartum period in a Brazilian public university hospital.

Materials and Methods In the present cohort study, we included women who received immediate postpartum IUD at vaginal delivery or cesarean s March 2018 to December 2019. Clinical data and the findings of transvaginal ultrasound (US) scans performed 6-weeks postpartum were collected. The expulsion and continuation rates were assessed 6-months postpartum using data from the electronic medical records or by telephone contact. The primary outcome was the proportion of IUDs expelled at 6 months. For the statistical analysis, we used the Student t-test, the Poisson distribution, and the Chi-squared test.

Results There were 3,728 births in the period, and 352 IUD insertions were performed, totaling a rate of 9.4%. At 6 weeks postpartum, the IUD was properly positioned in 65.1% of the cases, in 10.8% there was partial expulsion, and in 8.5% it had been completely expelled. At 6 months postpartum, information was obtained from 234 women, 74.4% of whom used IUD, with an overall expulsion rate of 25.6%. The expulsion rate was higher after vaginal delivery when compared with cesarean section (68.4% versus 31.6% respectively; p = 0.031). There were no differences in terms of age, parity, gestational age, final body mass index, and newborn weight.

Conclusion Despite the low insertion rate of copper IUDs in the postpartum period and a higher expulsion rate, the rate of long-term continuation of intrauterine contraception was high, indicating that it is a useful intervention to prevent unwanted pregnancies and to reduce short-interval birth.

Resumo

Objetivo Avaliar as taxas de expulsão e continuação do dispositivo intrauterino (DIU) de cobre inserido no pós-parto imediato em um hospital universitário brasileiro.

Materiais e Métodos Neste estudo de corte transversal, foram incluídas parturientes submetidas à inserção de DIU de cobre no pós-parto imediato entre março de 2018 e dezembro de 2019. Foram coletados dados clínicos e da ultrassonografia (US) transvaginal realizada após seis semanas. As taxas de expulsão e de continuação foram avaliadas após seis meses por meio de dados do prontuário ou por contato telefônico. O resultado principal foi a proporção de DIUs expelidos em seis meses. Para análise estatística, utilizaram-se o teste t de Student, a distribuição de Poisson, e o teste do Qui quadrado.

Resultados Houve 3,728 nascimentos no período, e foram inseridos 352 DIUs, em uma taxa de 9,4%. Com 6 semanas, o DIU estava bem posicionado em 65,1% dos casos, em 10,8%, houve expulsão parcial, e, em 8,5%, fora totalmente expelido. Aos 6 meses de pós-parto, foram obtidas informações de 234 mulheres, 74,4% das quais usavam DIU, com uma taxa de expulsão geral de 25,6%. A taxa de expulsão foi maior após o parto vaginal do que após cesariana (68,4% versus 31,6%, respectivamente; p = 0,031). Não houve diferenças quanto à idade, paridade, idade gestacional, índice de massa corpórea final, e peso do recém-nascido.

Conclusão Apesar da baixa taxa de inserção e alta taxa de expulsão, a taxa de continuação em longo prazo da contracepção intrauterina com DIU de cobre foi elevada, o que indica que se trata de intervenção útil para prevenir gestações indesejadas em curto intervalo de tempo.

Keywords

postpartum contraception - cooper intrauterine device - immediate postpartum insertion - expulsion rate - continuation rate

Palavras-chave

contracepção pós-parto - dispositivo intrauterino de cobre - inserção no pós-parto imediato - taxa de expulsão - taxa de continuação

Contributions

All authors participated in the concept and design of the present study; analysis and interpretation of data; draft or revision of the manuscript; and they have approved it as submitted. All authors are responsible for the reported research.

Publikationsverlauf

Eingereicht: 04. Oktober 2021

Angenommen: 08. September 2022

Artikel online veröffentlicht:
06. März 2023

• References

• 1 Wu JP, Moniz MH, Ursu AN. Long-acting reversible contraception-highly efficacious, safe, and underutilized. JAMA 2018; 320 (04) 397-398
• 2 Liberty A, Yee K, Darney BG, Lopez-Defede A, Rodriguez MI. Coverage of immediate postpartum long-acting reversible contraception has improved birth intervals for at-risk populations. Am J Obstet Gynecol 2020; 222 (4S):886.e1–e9, 886.e9
• 3 Wu M, Eisenberg R, Negassa A, Levi E. Associations between immediate postpartum long-acting reversible contraception and short interpregnancy intervals. Contraception 2020; 102 (06) 409-413
• 4 Peipert JF, Zhao Q, Allsworth JE, Petrosky E, Madden T, Eisenberg D, Secura G. Continuation and satisfaction of reversible contraception. Obstet Gynecol 2011; 117 (05) 1105-1113
• 5 Whitaker AK, Chen BA. Society of Family Planning Guidelines: Postplacental insertion of intrauterine devices. Contraception 2018; 97 (01) 2-13
• 6 World Health Organization. Medical eligibility criteria for contraceptive use: a WHO family planning cornerstone [Internet]. 5th ed. 2015 [cited 2021 Aug 13]. Available from: http://apps.who.int/iris/bitstream/10665/181468/1/9789241549158_eng.pdf
• 7 de Caestecker L, Banks L, Bell E, Sethi M, Arulkumaran S. Planning and implementation of a FIGO postpartum intrauterine device initiative in six countries. Int J Gynaecol Obstet 2018; 143 (Suppl. 01) 4-12
• 8 Goldthwaite LM, Cahill EP, Voedisch AJ, Blumenthal PD. Postpartum intrauterine devices: clinical and programmatic review. Am J Obstet Gynecol 2018; 219 (03) 235-241
• 9 Escobar M, Shearin S. Immediate postpartum contraception: intrauterine device insertion. J Midwifery Womens Health 2019; 64 (04) 481-487
• 10 Cooper M, Boydell N, Heller R, Cameron S. Community sexual health providers' views on immediate postpartum provision of intrauterine contraception. BMJ Sex Reprod Health 2018; 44 (02) 97-102
• 11 Gurney EP, Sonalkar S, McAllister A, Sammel MD, Schreiber CA. Six-month expulsion of postplacental copper intrauterine devices placed after vaginal delivery. Am J Obstet Gynecol 2018; 219 (02) 183.e1-183.e9
• 12 Lopez LM, Bernholc A, Hubacher D, Stuart G, Van Vliet HA. Immediate postpartum insertion of intrauterine device for contraception. Cochrane Database Syst Rev 2015; (06) CD003036
• 13 Averbach SH, Ermias Y, Jeng G, Curtis KM, Whiteman MK, Berry-Bibee E. et al. Expulsion of intrauterine devices after postpartum placement by timing of placement, delivery type, and intrauterine device type: a systematic review and meta-analysis. Am J Obstet Gynecol 2020; 223 (02) 177-188
• 14 Bachofner M, Blickenstorfer K, Hutmacher J, Wehrle L, Leeners B, Merki-Feld G. Intrauterine device continuation rates and reasons for discontinuation in a Central European clinic with a high standard of care and ultrasound follow-up: a retrospective cohort study. Eur J Contracept Reprod Health Care 2018; 23 (06) 407-414
• 15 Zaconeta AM, Oliveira AC, Estrela FS, Vasconcelos TM, França PS, Wanderley MS, Amato AA. Intrauterine device insertion during cesarean section in women without prenatal contraception counseling: lessons from a country with high cesarean rates. Rev Bras Ginecol Obstet 2019; 41 (08) 485-492
• 16 Hochmuller JT, Lopes KS, Guazzelli CAF, Gomes MKO, Araujo Júnior E, Peixoto AB. Expulsion rate of intrauterine device: mediate vs. immediate puerperium period. J Turk Ger Gynecol Assoc 2020; 21 (03) 143-149
• 17 Laporte M, Marangoni Jr M, Surita F, Juliato CT, Miadaira M, Bahamondes L. Postplacental placement of intrauterine devices: A randomized clinical trial. Contraception 2020; 101 (03) 153-158
• 18 Kraft MBPL, Miadaira M, Marangoni Jr M, Juliato CRT, Surita FG. Postplacental placement of intrauterine devices: acceptability, reasons for refusal and proposals to increase its use. Rev Bras Ginecol Obstet 2021; 43 (03) 172-177
• 19 Marangoni Jr M, Laporte M, Surita F, Kraft MB, Bahamondes L, Juliato CRT. One-year follow up on post-placental IUD insertion: A randomized clinical trial. Acta Obstet Gynecol Scand 2021; 100 (04) 596-603
• 20 American College of Obstetricians and Gynecologists' Committee on Obstetric Practice. Committee opinion No. 670: immediate postpartum long-acting reversible contraception. Obstet Gynecol 2016; 128 (02) e32-e37
• 21 Jatlaoui TC, Whiteman MK, Jeng G, Tepper NK, Berry-Bibee E, Jamieson DJ. Intrauterine device expulsion after postpartum placement: a systematic review and meta-analysis. Obstet Gynecol 2018; 132 (04) 895-905
• 22 Makins A, Taghinejadi N, Sethi M, Machiyama K, Munganyizi P, Odongo E. et al. FIGO postpartum intrauterine device initiative: Complication rates across six countries. Int J Gynaecol Obstet 2018; 143 (Suppl. 01) 20-27